Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Diffuse Large B-Cell Lymphoma

Known as: large cell diffuse lymphoma, DLBCL, Lymphoma, Diffuse Large Cell 
A non-Hodgkin lymphoma characterized by a diffuse proliferation of predominantly large neoplastic B lymphocytes. It is the most frequently seen type… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Introduction— Endovascular thrombectomy is a highly efficacious treatment for large vessel occlusion (LVO). LVO prediction… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2018
Review
2018
Author(s): Ata, M; Baumgarten, F; Bautista, J; Beutler, F; Bizyaev, D; Blanton, MR; Blazek, JA; Bolton, AS; Brinkmann, J… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Review
2018
Review
2018
Programmed cell death protein 1 (PD-1) blockade targeting the PD-1 immune checkpoint has demonstrated unprecedented clinical… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2018
Review
2018
New therapies are needed for patients with Hodgkin or non-Hodgkin lymphomas that are resistant to standard therapies. Indeed… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2017
Review
2017
Rituximab is a human/murine, chimeric anti-CD20 monoclonal antibody with established efficacy, and a favorable and well-defined… Expand
  • figure 1
  • table 1
  • table 1
Is this relevant?
Review
2017
Review
2017
Purpose Rituximab (R) plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy is the standard of care in… Expand
Is this relevant?
Review
2017
Review
2017
Manipulation of the ubiquitin-proteasome system to achieve targeted degradation of proteins within cells using chemical tools and… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
Review
2016
Review
2016
Salvage chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard second-line treatment for relapsed… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important subgroups with germinal center B-cell-like… Expand
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?